Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Dow
Mallinckrodt
Cantor Fitzgerald
McKinsey
Colorcon
Argus Health
Express Scripts
Moodys

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090619

« Back to Dashboard

NDA 090619 describes IBUPROFEN AND DIPHENHYDRAMINE CITRATE, which is a drug marketed by Dr Reddys Labs Ltd and Perrigo R And D and is included in two NDAs. It is available from thirty-one suppliers. Additional details are available on the IBUPROFEN AND DIPHENHYDRAMINE CITRATE profile page.

The generic ingredient in IBUPROFEN AND DIPHENHYDRAMINE CITRATE is diphenhydramine citrate; ibuprofen. There are twenty-three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.
Summary for 090619
Tradename:IBUPROFEN AND DIPHENHYDRAMINE CITRATE
Applicant:Dr Reddys Labs Ltd
Ingredient:diphenhydramine citrate; ibuprofen
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 090619
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IBUPROFEN AND DIPHENHYDRAMINE CITRATE diphenhydramine citrate; ibuprofen TABLET;ORAL 090619 ANDA Dr. Reddy's Laboratories Limited 55111-565 N 55111-565-14
IBUPROFEN AND DIPHENHYDRAMINE CITRATE diphenhydramine citrate; ibuprofen TABLET;ORAL 090619 ANDA Dr. Reddy's Laboratories Limited 55111-565 N 55111-565-80

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength38MG;200MG
Approval Date:Jul 8, 2009TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Healthtrust
Accenture
Dow
Farmers Insurance
AstraZeneca
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.